The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients

Transplantation

Volumn 58, Issue 2, 1994, Pages 245-247

  Boissonnat, Pascale ^a   Salen, Patricia ^a   Guidollet, Jeannine ^a   Ferrera, René ^a   Dureau, Georges ^a   Ninet, Jean ^a   Renaud, Serge ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CYCLOSPORIN; FENOFIBRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; FAT INTAKE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RASH; STEATORRHEA;

ADOLESCENT; ADULT; AGED; DRUG TOLERANCE; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; LIPIDS; LONGITUDINAL STUDIES; MIDDLE AGE; PROCETOFEN; PROSPECTIVE STUDIES;

EID: 0028000749     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199405820-00018     Document Type: Article

References (7)

1. Stamler JS, Vaughan DE, Rudd A, et al. Frequency of hypercho lesterolemia after cardiac transplantation. Am J Cardiol 1988; 62: 1268.
2. Rudas L, Pflugfelder PW, McKenzie N, Menkis AH, Novick RJ, Kostuk WJ. Serial evaluation of lipid profiles and risk factors for development of hyperlipiemia after cardiac transplantation. Am J Cardiol 1990; 66: 1135.
3. Knopp RH, Walden CE, Wamick GR, Albers JJ, Ginsberg J, McGinnis BM. Effects of fenofibrate treatment of plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, Al, All, and E. Am J Med 1987; 83: 75.
4. Brown WV, Dujovne CA, Farquhar JW, et al. Effects of fenofi brate on plasma lipids: double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia. Arteriosclerosis 1986; 6: 670.
5. De Lorgeril M, Boissonnat P, Bizollon CA, et al. Pharmacokinet ics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation: lack of interaction with the lipid-lowering agent fenofibrate. Eur J Clin Pharmacol 1992; 43: 161.
6. Barbir M, Hunt B, Kushwana S, et al. Maxepa versus bezafi-brate in hyperlipidemic cardiac transplant recipients. Am J Cardiol 1992; 70: 1596.
7. Butman SM. Hyperlipidemia after cardiac transplantation: be aware and possibly wary of drug therapy for lowering of serum lipids. Am Heart J 1991; 121: 1585.